BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31272709)

  • 21. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
    Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
    Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics.
    Gu Y; Wang J; Li K; Zhang L; Ren H; Guo L; Sai Y; Zhang W; Su W
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):95-115. PubMed ID: 24817647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.
    Zomorodi K; Kankam M; Lu Y
    Clin Ther; 2019 Feb; 41(2):196-204. PubMed ID: 30598342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and tolerability of minodronic acid tablets in healthy Chinese subjects and food and age effects on the pharmacokinetics.
    Zhou Y; He X; Li H; Ni Y; Xu M; Sattar H; Chen H; Li W
    Clin Ther; 2015 Apr; 37(4):869-76. PubMed ID: 25748293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.
    Tzanis E; Manley A; Villano S; Tanaka SK; Bai S; Loh E
    J Clin Pharmacol; 2017 Mar; 57(3):321-327. PubMed ID: 27539539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
    Rioux N; Kim A; Nix D; Bowser T; Warmuth M; Smith PG; Schindler J
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):91-96. PubMed ID: 30368584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.
    Hu L; Sun Q; Tang L; Cai M; Qian W; Dou T; Wang H; Wu Y; Liu Y
    Clin Drug Investig; 2024 Jan; 44(1):79-85. PubMed ID: 38112942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
    Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a high-calorie, high-fat meal on the bioavailability and pharmacokinetics of PA-824 in healthy adult subjects.
    Winter H; Ginsberg A; Egizi E; Erondu N; Whitney K; Pauli E; Everitt D
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5516-20. PubMed ID: 23979737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK-788) in Healthy Volunteers: Low-Fat Meal Effect and Relative Bioavailability of 2 Capsule Products.
    Zhang S; Jin S; Griffin C; Feng Z; Lin J; Baratta M; Brake R; Venkatakrishnan K; Gupta N
    Clin Pharmacol Drug Dev; 2021 Sep; 10(9):1028-1043. PubMed ID: 34118178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a high-fat and high-calorie food on the pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy subjects.
    Wu Q; Zhu H; Song R; Zhang M; Li F; Zeng W; Wang W; Jia J; Yu C; Liu Y
    Pharmacol Res Perspect; 2023 Jun; 11(3):e01102. PubMed ID: 37208866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects.
    Cao B; Ma T; Zhang Y; Huang L; Lin H; Jiang H; Zhao Y; Geng Y; Yang Y; Cao S; Li J
    Invest New Drugs; 2024 Jun; 42(3):289-298. PubMed ID: 38602625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I study to investigate the metabolism, excretion, and pharmacokinetics of [
    Zhou S; Shao F; Xu Z; Wang L; Jin K; Xie L; Chen J; Liu Y; Zhang H; Ou N
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):563-573. PubMed ID: 28730290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers.
    Wang Z; Chen X; Li A; Chen L; Wang Y; Zheng L
    Clin Ther; 2020 Dec; 42(12):2280-2288. PubMed ID: 33109386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects.
    Chen JJ; Hewitt LA
    Drugs R D; 2018 Mar; 18(1):77-86. PubMed ID: 29392574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
    Kinzler ER; Pantaleon C; Iverson M; Aigner S
    Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):39-52. PubMed ID: 26581327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.